Observational analysis shows similar Hp eradication rates in both bismuth and Saccharomyces boulardii groups, highlighting lower adverse events with the latter.
Key Points
The Saccharomyces boulardii group achieved a Hp eradication rate of 92.2%, which is comparable to the bismuth quadruple group at 93.8%.
Incidence of adverse events was significantly lower in the Saccharomyces boulardii group at 20.4% compared to 51.0% in the bismuth group.
Both treatment groups had similar follow-up periods, with a median time of 6.9 weeks overall.
A total of 398 patients were analyzed, with 206 in the Saccharomyces boulardii group and 192 in the bismuth group.